- [1]Chu X, Tian W, Wang Z, Zhang J, Zhou R. Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials. Mol Cancer. 2023 Jun 8;22(1):93. doi: 10.1186/s12943-023-01800-3. PMID: 37291608.
- [2]Niu L, Chu X, Yang X, et al. A multiomics approach-based prediction of radiation pneumonia in lung cancer patients: impact on survival outcome [published online ahead of print, 2023 May 8]. J Cancer Res Clin Oncol. 2023;10.1007/s00432-023-04827-7. doi:10.1007/s00432-023-04827-7
- [3]Tian W, Chu X, Tanzhu G, Zhou R. Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis. J Transl Med. 2023;21(1):244. Published 2023 Apr 5. doi:10.1186/s12967-023-04089-4
- [4]Chen L, Li Y, Dong X, et al. The value of postoperative radiotherapy in thymoma patients with myasthenia gravis [published online ahead of print, 2023 Mar 27]. Radiother Oncol. 2023;183:109644. doi:10.1016/j.radonc.2023.109644
- [5]Xiao G, Li L, Tanzhu G, et al. Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma. J Immunother Cancer. 2023;11(3):e006243. doi:10.1136/jitc-2022-006243
- [6]Niu L, Li X, Meng L, et al. Case report: Brain metastasis necrosis with immune checkpoint inhibitors plus chemotherapy for advanced non-small cell lung cancer. Front Immunol. 2022;13:1064596. Published 2022 Dec 1. doi:10.3389/fimmu.2022.1064596
- [7]Tanzhu G, Chen L, Xiao G, et al. The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy. Cell Death Discov. 2022;8(1):416. Published 2022 Oct 11. doi:10.1038/s41420-022-01206-y
- [8]Chu X, Niu L, Xiao G, et al. The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis. Front Immunol. 2022;13:875488. Published 2022 May 25. doi:10.3389/fimmu.2022.875488
- [9]段和新,田文韬,肖刚,等. 2021年恶性肿瘤脑转移研究现状和热点分析——基于CiteSpace可视化文献计量学研究[J]. 国际神经病学神经外科学杂志,2022,49(2):38-47. DOI:10.16636/j.cnki.jinn.1673-2642.2022.02.009
- [10]Xiao G, Liu Z, Gao X, et al. Immune checkpoint inhibitors for brain metastases in non-small-cell lung cancer: from rationale to clinical application. Immunotherapy. 2021;13(12):1031-1051. doi:10.2217/imt-2020-0262
- [11]Xiao G, Gao X, Li L, et al. An Immune-Related Prognostic Signature for Predicting Clinical Outcomes and Immune Landscape in IDH-Mutant Lower-Grade Gliomas. J Oncol. 2021;2021:3766685. Published 2021 Dec 18. doi:10.1155/2021/3766685
- [12]Liu Z, Jiang Z, Meng L, et al. Handcrafted and Deep Learning-Based Radiomic Models Can Distinguish GBM from Brain Metastasis. J Oncol. 2021;2021:5518717. Published 2021 Jun 3. doi:10.1155/2021/5518717
- [13]Song Z, Yang L, Zhou Z, et al. Genomic profiles and tumor immune microenvironment of primary lung carcinoma and brain oligo-metastasis. Cell Death Dis. 2021;12(1):106. Published 2021 Jan 21. doi:10.1038/s41419-021-03410-7
- [14]李战战,彭海芹,段和新,等. 肺癌脑转移研究进展：文献计量学和网络分析[J]. 中华转移性肿瘤杂志,2020,03(3):186-193. DOI:10.3760/cma.j.cn101548-20200527-00065
- [15]Rong R, Xia X, Peng H, et al. Cdk5-mediated Drp1 phosphorylation drives mitochondrial defects and neuronal apoptosis in radiation-induced optic neuropathy. Cell Death Dis. 2020;11(9):720. Published 2020 Sep 3. doi:10.1038/s41419-020-02922-y
- [16]近十年肺癌放疗研究现状及发展趋势——基于Web of Science文献计量学分析[J].中华放射肿瘤学杂志, 29 (6)
- [17]Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis[J].Human gene therapy, 30 (12)
- [18]Clinical value of a plasma Epstein-Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis[J].Bioscience reports, 39 (9)
- [19]Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma[J].Cancer management and research
- [20]Synchronous primary carcinomas of the prostate, thyroid and rectum: case report and review of the literature[J].Translational Cancer Research, 8 (3)